iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Hester Bio jumps on bagging Rs 60 cr grant from BIRAC

8 Apr 2022 , 02:24 PM

In their board meeting on Thursday, the company has approved the execution of grant-in-aid letter agreement for grant in phased manner.

Board of Directors, in their Meeting held today, have approved the execution of Grant-in-Aid Letter Agreement for grant of INR 600 million (in phased manner) to the Company by Biotechnology Industry Research Assistance Council (BIRAC), a Government of India Enterprise to support COVID vaccine manufacturing under Mission Covid Suraksha, Hester Biosciences said in a statement on Thursday.

Hester Biosciences is part of Gujarat Covid Vaccine Consortium (GCVC), which comprises Gujarat Biotechnology Research Centre (GBRC) (a Government of Gujarat undertaking), Hester Biosciences and Omnibrx Biotechnologies.

GCVC, in May 2021, signed a pact with Bharat Biotech International towards contract manufacturing for the drug substance for Covaxin. As per the pact, Bharat Biotech will provide the technology for the production of the drug substance for Covaxin, a COVID-19 vaccine. Covaxin is a registered trade mark of Bharat Biotech.

Hester Biosciences will provide the complete infrastructure at its Gujarat plant for the manufacturing of the drug substance. GBRC will act as an advisor and will facilitate the technology transfer from Bharat Biotech. Lastly, Omnibrx Biotechnologies shall act as a technology support partner.

Hester Biosciences is one of Indias leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country.

The company reported 31% fall in consolidated net profit to Rs 8.48 crore on a 2% decline in revenue from operations to Rs 55.69 crore in Q3 FY22 over Q3 FY21.

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.